Side-by-Side Comparison of Five Chelators for
3,4,3-(LI-1,2-HOPO)
89Zr
CHT-36
DFO
DFO*
DOTA-GA
bioconjugation
complex inertness
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
17 Dec 2021
17 Dec 2021
Historique:
received:
15
11
2021
revised:
01
12
2021
accepted:
14
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
In this work, five different chelating agents, namely DFO, CTH-36, DFO*, 3,4,3-(LI-1,2-HOPO) and DOTA-GA, were compared with regard to the relative kinetic inertness of their corresponding
Identifiants
pubmed: 34944969
pii: cancers13246349
doi: 10.3390/cancers13246349
pmc: PMC8699488
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Wilhelm Sander Stiftung
ID : 2018.086.1
Références
ChemMedChem. 2015 Jul;10(7):1200-8
pubmed: 26011290
Nat Chem Biol. 2007 Oct;3(10):652-6
pubmed: 17704771
Chembiochem. 2010 Oct 18;11(15):2168-81
pubmed: 20827791
Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789
pubmed: 9944570
Molecules. 2013 Jun 03;18(6):6469-90
pubmed: 23736785
Bioconjug Chem. 2008 Apr;19(4):951-7
pubmed: 18341272
J Nucl Med. 2021 Apr;62(4):438-445
pubmed: 33277395
Molecules. 2018 Mar 12;23(3):
pubmed: 29534538
J Am Chem Soc. 2018 Mar 14;140(10):3603-3612
pubmed: 29384666
Molecules. 2014 Jul 17;19(7):10455-72
pubmed: 25036155
Theranostics. 2013 Aug 03;3(9):618-32
pubmed: 24052804
EJNMMI Res. 2011 Dec 01;1(1):31
pubmed: 22214225
J Nucl Med. 2015 Jul;56(7):1100-5
pubmed: 25977461
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):694-707
pubmed: 32889615
Org Biomol Chem. 2019 Jul 17;17(28):6866-6871
pubmed: 31268109
Cancers (Basel). 2021 Sep 04;13(17):
pubmed: 34503276
Inorg Chem. 2020 Feb 3;59(3):2070-2082
pubmed: 31940188
Nucl Med Biol. 2018 Sep - Oct;64-65:1-7
pubmed: 30015090
Angew Chem Int Ed Engl. 2013 Dec 23;52(52):14112-6
pubmed: 24281986
Bioconjug Chem. 2016 Dec 21;27(12):2791-2807
pubmed: 27787983
Int J Mol Sci. 2020 Jun 17;21(12):
pubmed: 32560337
J Am Chem Soc. 2020 Jun 24;142(25):10955-10963
pubmed: 32453557
Chem Sci. 2017 Mar 1;8(3):2309-2314
pubmed: 28451334
J Nucl Med. 2013 Jun;54(6):829-32
pubmed: 23616581
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):286-295
pubmed: 27573793
ChemMedChem. 2017 Sep 21;12(18):1555-1571
pubmed: 28715615
Chem Commun (Camb). 2014 Oct 9;50(78):11523-5
pubmed: 25132321
Sci Rep. 2017 Jan 11;7:39805
pubmed: 28074920
J Med Chem. 2002 Aug 29;45(18):3963-71
pubmed: 12190318
Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098-3100
pubmed: 9900728
Phys Chem Chem Phys. 2006 Jul 21;8(27):3172-91
pubmed: 16902710
ACS Omega. 2018 Oct 31;3(10):14039-14053
pubmed: 30411057
J Labelled Comp Radiopharm. 2014 Apr;57(4):285-90
pubmed: 24347429
Bioconjug Chem. 2015 Dec 16;26(12):2579-91
pubmed: 26550847
Chem Soc Rev. 2017 Aug 14;46(16):4895-4950
pubmed: 28660957
J Med Chem. 2014 Jun 12;57(11):4849-60
pubmed: 24814511